INRD yields 183.49% · PFE yields 6.13%● Live data
📍 INRD pulled ahead of the other in Year 1
Combined, INRD + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INRD + PFE for your $10,000?
Inrad Optics, Inc., together with its subsidiaries, develops, manufactures, and markets crystal-based optical components and devices, custom optical components, and precision optical and opto-mechanical assemblies worldwide. The company provides optical components, optical coatings, and subassemblies; and UV filter optical components for use in critical applications in defense systems, such as missile warning sensors, as well as opto-mechanical design and assembly services. Its optical components include planar, prismatic, and spherical components fabricated from glass and synthetic crystals; and various components consist of large form factor transmission flats, optical windows for airborne applications, multi-element optical assemblies, lenses, mirrors, polarizing optics, prisms, wave plates, and x-ray monochromators. The company also offers laser devices and instrumentation products comprising electro-optic and nonlinear crystal devices for altering the intensity, polarization, or wavelength of a laser beam, as well as other crystal components for use in laser research, in commercial laser systems, and in detection of fast neutrons; and pockels' cells and associated electronics. It also serves corporations in the laser system, process control, and metrology sectors of the photonics industry, as well as the United States Government, national laboratories, universities, and institutions. The company markets its products through sales, marketing, and customer service teams, as well as through independent sales agents. Inrad Optics, Inc. also exports its products Europe, Israel, and Asia. The company was formerly known as Photonic Products Group, Inc. and changed its name to Inrad Optics, Inc. in 2012. Inrad Optics, Inc. was incorporated in 1973 and is based in Northvale, New Jersey.
Full INRD Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.